The writing committee consisted of acknowledged experts in the field of CTA, as well as a
liaison from the ACCF Task Force on Clinical ECDs, the oversight group for this document …

Cardiac allograft vasculopathy (CAV) continues to limit the long-term success of cardiac
transplantation. Recent insights have underscored the fact that innate and adaptive immune …

CHAIR: Costanzo MR: Midwest Heart Foundation, Lombard Illinois, USA TASK FORCE 1:
Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland …

The development of cardiac allograft vasculopathy remains the Achilles heel of cardiac
transplantation. Unfortunately, the definitions of cardiac allograft vasculopathy are diverse …

Objectives: This study aimed to evaluate the diagnostic accuracy of coronary computed
tomography angiography (CCTA) for detecting cardiac allograft vasculopathy (CAV) in …

Background Numerous studies have compared coronary CT angiography (CTA) with
quantitativecoronary angiography. However, the ability of coronary CTA to identify …

Since the introduction of computed tomography (CT) over 30 years ago, the challenge of
imaging the beating heart has been a driving force in the innovation of cardiac CT. Imaging …

Cardiac allograft vasculopathy (CAV) is an important cause of morbidity and mortality among
cardiac transplant recipients. CAV occurs in approximately 30% of patients by 5 years and …

Transplant coronary artery disease (TCAD) remains the most significant cause of morbidity
and mortality after orthotopic heart transplantation. Transplant coronary artery disease is …

Background Cardiac allograft vasculopathy (CAV), a major cause of graft failure and
mortality at> 3 years after orthotopic heart transplantation (OHT), is commonly evaluated …